Bayer CropScience Q2 FY19 earnings call: Revenue & Margins
Q2 FY19 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #15 of 23 in Fertilizers & Agrochemicals
See the sector's top 10 — free with your mobile number.
Based on Bayer CropScience Ltd's Q2 FY19 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q3 2018 Key Data (Page 5): - Sales: €9,905 million - Year-on-year change (currency- and portfolio-adjusted): +4.1% - Crop Science segment sales: €3,733 million, -9.5% - EBITDA: 304 million, -13.5% - First Nine Months of 2018 Key Data (Page 6): - Sales: €28,524 million - Year-on-year change (currency- and portfolio-adjusted): +3.6% - Crop Science segment sales: €9,605 million, +3.2% - Quarterly EBITDA: INR 1,297 million, up +3.0% YoY (Page 5) - However, FY18 EBITDA margin reported at 14.9% (Page 15) - Profit Before Tax shows a +13% increase YoY (Page 19) - Other financial figures: - Revenue for the year ended March 31, 2018, BCSL: INR 27,490 million; MIL: INR 6,721 million (Page 15) - EBITDA margin BCSL: 14.9%, MIL: 25.2% (Page 15)
From Bayer CropScience Ltd's Q2 FY19 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q3 2018 Key Data (Page 5):
- Sales: €9,905 million
- Year-on-year change (currency- and portfolio-adjusted): +4.1%
- Crop Science segment sales: €3,733 million, -9.5%
- EBITDA: 304 million, -13.5%
- First Nine Months of 2018 Key Data (Page 6):
- Sales: €28,524 million
- Year-on-year change (currency- and portfolio-adjusted): +3.6%
- Crop Science segment sales: €9,605 million, +3.2%
- Outlook (Pages 26, 27, 28):
- Business expected to return to growth in remainder of FY 2018-19
- Launch of 2 products till Q4 FY 2018-19 and 5 more thereafter expected to capture market value
2 more points from Bayer CropScience Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
See what Bayer CropScience Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Bayer CropScience Ltd's call on order book
Create a free account to keep reading this call
Bayer CropScience Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Bayer CropScience's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Aries Agro (Q2 FY19)
The company achieved a conversion rate of approximately 75-80% from these orders. Key concall takeaways from Aries Agro Ltd's Q2 FY19 earnings call — and how…
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Insecticides IndiaGood growth2
- Anya Polytech &Good growth1
- Madhya Bharat Agro ProductsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Bayer CropScience Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Bayer CropScience Ltd Q2 FY19 results?
Q3 2018 Key Data (Page 5): - Sales: €9,905 million - Year-on-year change (currency- and portfolio-adjusted): +4.1% - Crop Science segment sales: €3,733 million, -9.5% - EBITDA: 304 million, -13.5% - First Nine Months of 2018 Key Data (Page 6): - Sales: €28,524 million - Year-on-year change (currency- and portfolio-adjusted): +3.6% - Crop Science segment sales: €9,605 million, +3.2% - Quarterly EBITDA: INR 1,297 million, up +3.0% YoY (Page 5) - However, FY18 EBITDA margin reported at 14.9% (Page 15) - Profit Before Tax shows a +13% increase YoY (Page 19) - Other financial figures: - Revenue for the year ended March 31, 2018, BCSL: INR 27,490 million; MIL: INR 6,721 million (Page 15) - EBITDA margin BCSL: 14.9%, MIL: 25.2% (Page 15)
What is Bayer CropScience Ltd share price analysis?
Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 23.2 with a market cap of ₹16,986 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
